These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 17406481)

  • 21. Biochemical engineering of the N-acyl side chain of sialic acid: biological implications.
    Keppler OT; Horstkorte R; Pawlita M; Schmidt C; Reutter W
    Glycobiology; 2001 Feb; 11(2):11R-18R. PubMed ID: 11287396
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences in the incorporation of N-(acetyl-3 H)mannosamine into the sialic acid of the major retinal gangliosides, studied in vivo.
    Holm M; Månsson JE
    FEBS Lett; 1974 Sep; 46(1):200-2. PubMed ID: 4420170
    [No Abstract]   [Full Text] [Related]  

  • 23. Giving cells a new sugar-coating.
    Howarth M; Ting AY
    Nat Chem Biol; 2006 Mar; 2(3):127-8. PubMed ID: 16485002
    [No Abstract]   [Full Text] [Related]  

  • 24. Integration of genetic and metabolic features related to sialic acid metabolism distinguishes human breast cell subtypes.
    Saeui CT; Nairn AV; Galizzi M; Douville C; Gowda P; Park M; Dharmarha V; Shah SR; Clarke A; Austin M; Moremen KW; Yarema KJ
    PLoS One; 2018; 13(5):e0195812. PubMed ID: 29847599
    [TBL] [Abstract][Full Text] [Related]  

  • 25. N-acetyl-D-mannosamine analogues as potential inhibitors of sialic acid biosynthesis.
    Hadfield AF; Mella SL; Sartorelli AC
    J Pharm Sci; 1983 Jul; 72(7):748-51. PubMed ID: 6577183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic Glycoengineering with Azide- and Alkene-Modified Hexosamines: Quantification of Sialic Acid Levels.
    Dold JEGA; Wittmann V
    Chembiochem; 2021 Apr; 22(7):1243-1251. PubMed ID: 33180370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigating cellular metabolism of synthetic azidosugars with the Staudinger ligation.
    Saxon E; Luchansky SJ; Hang HC; Yu C; Lee SC; Bertozzi CR
    J Am Chem Soc; 2002 Dec; 124(50):14893-902. PubMed ID: 12475330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dienophile-Modified Mannosamine Derivatives for Metabolic Labeling of Sialic Acids: A Comparative Study.
    Dold JEGA; Pfotzer J; Späte AK; Wittmann V
    Chembiochem; 2017 Jul; 18(13):1242-1250. PubMed ID: 28318083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Engineering the sialic acid in organs of mice using N-propanoylmannosamine.
    Gagiannis D; Gossrau R; Reutter W; Zimmermann-Kordmann M; Horstkorte R
    Biochim Biophys Acta; 2007 Feb; 1770(2):297-306. PubMed ID: 17110045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Substrate specificity of the sialic acid biosynthetic pathway.
    Jacobs CL; Goon S; Yarema KJ; Hinderlich S; Hang HC; Chai DH; Bertozzi CR
    Biochemistry; 2001 Oct; 40(43):12864-74. PubMed ID: 11669623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of the metabolic flux and apoptotic effects of O-hydroxyl- and N-acyl-modified N-acetylmannosamine analogs in Jurkat cells.
    Kim EJ; Sampathkumar SG; Jones MB; Rhee JK; Baskaran G; Goon S; Yarema KJ
    J Biol Chem; 2004 Apr; 279(18):18342-52. PubMed ID: 14966124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic Glycoengineering of Sialic Acid Using N-acyl-modified Mannosamines.
    Wratil PR; Horstkorte R
    J Vis Exp; 2017 Nov; (129):. PubMed ID: 29286437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A crosslinked inclusion body process for sialic acid synthesis.
    Nahálka J; Vikartovská A; Hrabárová E
    J Biotechnol; 2008 Mar; 134(1-2):146-53. PubMed ID: 18313163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of chemical and enzymatic synthesis of 2-acetamido-2-deoxy-D-mannose 6-phosphate: a new approach.
    Liu MZ; Lee YC
    Carbohydr Res; 2001 Feb; 330(3):413-9. PubMed ID: 11270821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extracellular and intracellular esterase processing of SCFA-hexosamine analogs: implications for metabolic glycoengineering and drug delivery.
    Mathew MP; Tan E; Shah S; Bhattacharya R; Adam Meledeo M; Huang J; Espinoza FA; Yarema KJ
    Bioorg Med Chem Lett; 2012 Nov; 22(22):6929-33. PubMed ID: 23041156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Purification and characterization of GlcNAc-6-P 2-epimerase from Escherichia coli K92.
    Ferrero MA; Martínez-Blanco H; Lopez-Velasco FF; Ezquerro-Sáenz C; Navasa N; Lozano S; Rodríguez-Aparicio LB
    Acta Biochim Pol; 2007; 54(2):387-99. PubMed ID: 17565386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison in vitro of the incorporation of [3H]-leucine and N-acetyl-[14C]-mannosamine into proteins and glycoproteins of the parotid, submandibular and sublingual glands of the mouse.
    Nieuw Amerongen AV; Aarsman ME; Vreugdenhil AP; Roukema PA
    Arch Oral Biol; 1981; 26(8):651-6. PubMed ID: 6947770
    [No Abstract]   [Full Text] [Related]  

  • 38. UDP-GlcNAc2-epimerase regulates cell surface sialylation and ceramide-induced cell death in human malignant lymphoma.
    Suzuki O; Tasaki K; Kusakabe T; Abe M
    Int J Mol Med; 2008 Sep; 22(3):339-48. PubMed ID: 18698493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigation into an efficient synthesis of 2,3-dehydro-N-acetyl neuraminic acid leads to three decarboxylated sialic acid dimers.
    Horn EJ; Saludes JP; Gervay-Hague J
    Carbohydr Res; 2008 Apr; 343(5):936-40. PubMed ID: 18282561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Near-infrared light controlled fluorogenic labeling of glycoengineered sialic acids in vivo with upconverting photoclick nanoprobe.
    Wu Y; Zheng J; Xing D; Zhang T
    Nanoscale; 2020 May; 12(18):10361-10368. PubMed ID: 32369049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.